November 24, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
Company
News Sectors
Automotive
Communications
Consumers
CSR
Electronics
Energy
Environment
Financial
Health & Med
Industrial
IT & Internet
Materials
Real Estate
Science & Research
Telecoms
Trade
Transportation
Departments
Annual Reports
Companies
News Alerts
News Search
Photo Gallery
Company Login
Japan Corporate News Network
About JCN
Privacy Policy
RSS  
Terms of Use
 
 
 
Suprema Provides Palm-print Live Scanners to Poland & Lithuania
Suprema Provides Palm-print Live Scanners to Poland & Lithuania
Seoul, Nov 23, 2010 - (ACN Newswire) - Suprema, Inc., a global leader in biometrics and ID solutions, announced today that the company's RealScan-F palm-print live scanner has been selected for the AFIS systems of the Polish National Police and Lithuania's Citizenship & Migration Affairs.   [ more... ]

 Headline News

Otsuka Group Establishes New Company; Strengthens Presence in Vending Machine Market (Nov 17, 2014)
Otsuka Pharmaceutical Co., Ltd. and Otsuka Foods Co., Ltd. have announced the establishment of Otsuka Wellness Vending Co., Ltd., a new corporate subsidiary that will focus on vending machine business. more info >>
Otsuka's 'QuickNavi-Flu' Diagnostic Kit to Provide Additional Diagnosis-Related Information (Oct 14, 2014)
Otsuka Pharmaceutical's QuickNavi(TM)-Flu, a rapid diagnostic test kit for the influenza virus, has the leading market share in Japan among products in this category. more info >>
Nitto Denko Anti-fibrosis Drug Starts Phase-1b Dosing for Cirrhosis Patients in the US (Oct 10, 2014)
Nitto Denko Corporation (Nitto) announced the initiation of a phase-1b clinical study in the US started in September 2014, to administer a new anti-fibrosis drug in patients for the assessment of safety and efficacy. more info >>
Mitsui to Participate in KIFMEC Specific Purpose Company (Aug 18, 2014)
Mitsui & Co. has invested in "KIFMEC specific purpose company" which has been established in order to lease a hospital building to Kobe International Frontier Medical Center ("KIFMEC"). more info >>
Yokogawa Technology Selected for JSTA's Next-generation Technology Transfer Program (Aug 8, 2014)
Yokogawa Electric announced that its confocal image single-cell drug discovery support system has been selected for the Japan Science and Technology Agency's (JST) next-generation technology transfer program (NexTEP). more info >>
ACN Newswire
 Press Release News

JCI Pharmaceutical Co., Ltd. Receives Approval from US FDA for Colloidal Iodine Formulation (Nov 20, 2014)
JCI Pharmaceutical Co., Ltd. has announced approval by the US FDA for its MN colloid iodine (C.I.M.N), a formulation utilizing a world-first technology for converting iodine into a colloidal state to make it absorbable into the body at a large doses. more info >>
DOCOMO and ToMMo to Jointly Research Pregnancy Disease Prevention & Early Detection (Nov 19, 2014)
NTT DOCOMO, INC., a personalized mobile solutions provider for smarter living, and Tohoku University Tohoku Medical Megabank Organization (ToMMo) announced that they have launched a joint research project today to establish mobile healthcare-enabled methods for the prevention and early detection of medical conditions common during pregnancies, including hypertension syndromes, diabetes and premature deliveries. more info >>
Eisai's Ranking Significantly Increases in the Access to Medicine Index 2014 (Nov 17, 2014)
Eisai Co., Ltd. announced today that Eisai has been ranked 11th among the world's leading pharmaceutical companies in the Access to Medicine Index (ATM Index) 2014, representing a significant increase of four places from its previous ranking in 2012. more info >>
Bispebjerg and Frederiksberg University Hospital and Hitachi Agree to Begin Studies Targeting Joint Development of IT Driven Solutions to Increase Efficiency of Hospital Management (Nov 5, 2014)
Bispebjerg and Frederiksberg University Hospital and Hitachi, Ltd. today announced that they have reached an agreement to undertake studies targeting joint development of solutions for increasing the efficiency of hospital management using IT.
more info >>

Lorcaserin Meets Primary Endpoint and Confirms Proof-Of-Concept as Potential Aid for Smoking Cessation in Investigational Phase II Clinical Study (Nov 4, 2014)
Eisai Co., Ltd. announced today that in a Phase II clinical study investigating the serotonin 2C receptor agonist lorcaserin hydrochloride as a potential aid for smoking cessation conducted by Arena Pharmaceuticals, Inc. and its U.S. subsidiary Eisai Inc., lorcaserin demonstrated a statistically significant increase in the study's primary endpoint of continuous quit rate compared to placebo, thus confirming proof-of-concept. more info >>
 Global Press Release

JCI Pharmaceutical Co., Ltd. Receives Approval from US FDA for Colloidal Iodine Formulation (Nov 20, 2014)

DOCOMO and ToMMo to Jointly Research Pregnancy Disease Prevention & Early Detection (Nov 19, 2014)

Eisai's Ranking Significantly Increases in the Access to Medicine Index 2014 (Nov 17, 2014)

Bispebjerg and Frederiksberg University Hospital and Hitachi Agree to Begin Studies Targeting Joint Development of IT Driven Solutions to Increase Efficiency of Hospital Management (Nov 5, 2014)

Lorcaserin Meets Primary Endpoint and Confirms Proof-Of-Concept as Potential Aid for Smoking Cessation in Investigational Phase II Clinical Study (Nov 4, 2014)

 ::: Listed Health & Pharm Companies
 Biotechnology  Healthcare
 Medical Products  Pharmaceutical
JCN Network - Company Profiles - Company Listing
 
CSR Report Download
Most Popular
About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)